Alfacalcidol - CAS 41294-56-8
Catalog number: B0084-068405
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C27H44O2
Molecular Weight:
400.65
COA:
Inquire
Targets:
VD/VDR
Description:
A synthetic analog of Calcitiol (the hormonal form of vitamin D3), which shows identical potency with respect to stimulation of intestinal calcium absorption and bone mineral mobilization. Vitamin D source.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-068405 50 mg $398 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
active metabolite of Vitamin D
Purity:
>98%
Appearance:
White to Off-White Solid
Synonyms:
1-Hydroxycholecalciferol; Alfarol; EinsAlpha; Alpha-Calcidol; One-Alpha; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
MSDS:
Inquire
Shelf Life:
2 years
Melting Point:
>121 °C (dec.)
InChIKey:
OFHCOWSQAMBJIW-AVJTYSNKSA-N
InChI:
InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1
Canonical SMILES:
CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
1.High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients.
Jean G1, Chazot C, Bresson E, Zaoui E, Cavalier E. Nephron. 2016;132(3):181-90. doi: 10.1159/000443845. Epub 2016 Feb 19.
BACKGROUND: Sclerostin is an osteocyte hormone that decreases osteoblastogenesis. Sclerostin may play a key role in osteoporosis and also in vascular calcification (VC). In chronic kidney disease and haemodialysis (HD) patients, serum sclerostin levels are high.
2.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M1,2, Che RC1,2, Hu CY1,2, Du XH1,2, Ding GX1,2, Huang SM1,2, Chen Y3,4,5, Zhang AH1,2. World J Pediatr. 2016 May;12(2):236-42. doi: 10.1007/s12519-015-0058-7. Epub 2015 Dec 18.
BACKGROUND: The information about the use of off-label drugs in pediatric nephrology is still lacking, which leads to increased adverse reactions and medical disputes. We retrospectively analyzed the use of off-label drugs in the in-patient ward of the nephrology department of Nanjing Children's Hospital, China in order to provide more complete information about the use of drugs for children.
3.Effects of 1α-Calcidol (Alfacalcidol) on Microvascular Endothelial Function, Arterial Stiffness, and Blood Pressure in Type II Diabetic Nephropathy Patients.
Munisamy S1, Daud KM2, Mokhtar SS1, Rasool AH1. Microcirculation. 2016 Jan;23(1):53-61. doi: 10.1111/micc.12256.
OBJECTIVES: To determine the effects of six months alfacalcidol on microvascular endothelial function, arterial stiffness, and BP in DN patients.
4.Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry.
Huish SA1, Fletcher S2, Dunn JA3, Hewison M4, Bland R5. J Steroid Biochem Mol Biol. 2016 Feb 11. pii: S0960-0760(16)30023-1. doi: 10.1016/j.jsbmb.2016.02.009. [Epub ahead of print]
Low serum 25(OH)D and associated bone and non-bone related problems are not well appreciated in end stage renal disease (ESRD). Vitamin D treatment strategies in the UK currently focus almost exclusively on calcitriol [1,25(OH)2D], alfacalcidol or paricalcitol. In ESRD hypovitaminosis D is associated with bone loss, muscle weakness, falls, fractures and increased inflammation. National guidelines changed in 2014 and now recommend the diagnosis and treatment of low serum 25(OH)D in all patients with glomerular filtration rate (GFR) less than 30ml/min/1.73m2. However as yet there are no standardized guidelines for dosage, frequency and monitoring in ESRD patients. Following a systematic review of the literature we developed a clinical guideline for cholecalciferol supplementation at University Hospitals of Coventry and Warwickshire, UK. The guideline recommends 40,000IU cholecalciferol weekly for patients with 25(OH)D <50nmol/L and 20,000IU weekly for patients with 25(OH)D 50-75nmol/L; to be continued long term unless levels increase to ≥150nmol/L.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related VD/VDR Products


CAS 103909-75-7 Maxacalcitol

Maxacalcitol
(CAS: 103909-75-7)

Maxacalcitol is non-calcemic vitamin D3 analog and ligand of VDR-like receptors.

CAS 93129-94-3 Tacalcitol monohydrate

Tacalcitol monohydrate
(CAS: 93129-94-3)

Tacalcitol monohydrate is a VDR-like Receptor promotes normal bone development by regulating calcium. It modulates immunological and inflammatory processes and ...

CAS 83805-11-2 Falecalcitriol

Falecalcitriol
(CAS: 83805-11-2)

Falecalcitriol is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.

CAS 19356-17-3 Calcifediol

Calcifediol
(CAS: 19356-17-3)

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 μM. It also suppresses PTH secretion ...

CAS 32222-06-3 Calcitriol

Calcitriol
(CAS: 32222-06-3)

Calcitriol is the hormonally active form of vitamin D.

CAS 126860-83-1 MC 1046

MC 1046
(CAS: 126860-83-1)

MC 1046 is a vitamin D3 analogue with similar effects. Impurity of Calcipotriol, an antipsoriatic.

CAS 55721-11-4 Secalciferol

Secalciferol
(CAS: 55721-11-4)

Secalciferol is a metabolite of Vitamin D, a possibly anti-inflammatory steroid which is involved in bone ossification. lt mediates calcium and phosphorus homeo...

CAS 57333-96-7 Tacalcitol

Tacalcitol
(CAS: 57333-96-7)

Tacalcitol promotes normal bone development by regulating calcium and modulates immunological and inflammatory processes. lt induces nerve growth factor product...

CAS 511-28-4 Vitamin D4

Vitamin D4
(CAS: 511-28-4)

Vitamin D4 is the active analogue of Vitamin D.

CAS 163018-26-6 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3

3-O-(2-Aminoethyl)-25-hydroxyvitamin D3
(CAS: 163018-26-6)

Vitamin D3 analog.

CAS 112828-09-8 (24R)-MC 976

(24R)-MC 976
(CAS: 112828-09-8)

(24R)-MC 976 is a Vitamin D3 derivative.

CAS 143032-85-3 1α-Hydroxy VD4

1α-Hydroxy VD4
(CAS: 143032-85-3)

1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative,&nbsp; can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.

CAS 50-14-6 Vitamin D2

Vitamin D2
(CAS: 50-14-6)

Vitamin D2 is a selective inhibitor of mammalian DNA polymerase A (pol A) with IC50 of 123 mM.

CAS 134404-52-7 Seocalcitol

Seocalcitol
(CAS: 134404-52-7)

Seocalcitol is a vitamin D receptor (VDR) agonist. Seocalcitol exhibits anti-tumor and anti-proliferative activity with reduced hypercalcemic effects

CAS 112849-14-6 (24S)-MC 976

(24S)-MC 976
(CAS: 112849-14-6)

(24S)-MC 976 is a Vitamin D3 derivative.

CAS 129831-99-8 MC 976

MC 976
(CAS: 129831-99-8)

MC 969 is an analog of the calcemic drug 1α-hydroxyvitamin D3 (1α-OH-D3) in which carbons 25, 26, and 27 in the side chain are incorporated into a cyclopropane ...

CAS 457048-34-9 1α, 24, 25-Trihydroxy VD2

1α, 24, 25-Trihydroxy VD2
(CAS: 457048-34-9)

1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.

CAS 112965-21-6 Calcipotriol

Calcipotriol
(CAS: 112965-21-6)

Calcipotriol, a 1,25-Dihydroxyvitamin D3 analogue, is used as topical treatment for psoriasis.

CAS 131918-61-1 Paricalcitol

Paricalcitol
(CAS: 131918-61-1)

Synthetic analog of vitamin D. Antihyperparathyroid.

CAS 199798-84-0 BXL 628

BXL 628
(CAS: 199798-84-0)

BXL 628 is a vitamin D3 analogue that competes with vitamin D receptor (VDR) for inhibition of prostate cell growth and RhoA/Rho-kinase signaling, a calcium sen...

Chemical Structure

CAS 41294-56-8 Alfacalcidol

Quick Inquiry

Verification code

Featured Items